Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Becker SJ, Garner B, Hartzler B, Rash C, Murphy C, Moul S, Yap K, Yermash J, Ball E, Roosa M, Madden L. Maximizing implementation of contingency management in opioid treatment programs: Process data from the first cohort of a type 3 hybrid trial. [conference abstract]. Addiction Science & Clinical Practice 2020;15(suppl2):A60. [doi: 10.1186/s13722-020-00208-4]
  2. Hallgren K, Witwer E, West I, Baldwin LM, Donovan DM, Stuvek BK, Keppel G, Mollis B, Stephens K. Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network. Journal of Substance Abuse Treatment 2020;110:18-27. [doi: 10.1016/j.jsat.2019.11.008] PMID: 31952624 PMCID: PMC7255441
  3. Haggerty KP, Carlini BH. Understanding the intergenerational transmission of substance use and problem behavior: Implications for future research and preventive interventions. Psychology of Addictive Behaviors 2020;34(8):894-897 [doi: 10.1037/adb0000624] PMID: 33271036
  4. Lyons VH, Benson LR, Griffin E, Floyd AS, Kiche SW, Haggerty KP, Whiteside L, Conover S, Herman DB, Rivara FP, Rowhani-Rahbar A. Fidelity assessment of a social work-led intervention among patients with firearm injuries. Research on Social Work Practice 2020;30(6):378-687. [doi: 10.1177/1049731520912002] PMID: 32973371 PMCID: PMC7508463
  5. Banta-Green CJ, Tinsley J, Hood J, Glick S, Finegood B, Williams J, Smith R. National Drug Early Warning System (NDEWS) Seattle Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2020. College Park, MD: Center for Substance Abuse Research, National Institute on Drug Abuse, August 2020, 18p.
  6. Firth CL, Davenport S, Smart R, Dilley J. How high: Differences in the developments of cannabis markets in two legalized states. International Journal of Drug Policy 2020;75:102611. [doi: 10.1016/j.drugpo.2019.102611] PMID: 31786435 PMCID: PMC7041961
  7. Firth C, Carlini BH, Dilley J, Wakefield J, Hajat A. Moving towards equity: Neighborhood deprivation and cannabis retailers across Portland, Oregon. Cannabis 2020;3(2):157-172
  8. Yap K, Fuentes D, Moul S, Murphy C, Hartzler B, Garner B, Becker SJ. Influence of opioid treatment provider attitudes on skill and knowledge after contingency management training. [conference abstract]. Addiction Science and Clinical Practice 2020;15(suppl2):A57. [doi: 10.1186/s13722-020-00208-4]
  9. Crummy EA, Donckels EA, Baskin BM, Bentzley BS, Ferguson SM. The impact of cocaine and heroin drug history on motivation and cue sensitivity in a rat model of polydrug abuse. Psychopharmacology 2020;237(1):55-68. [doi: 10.1007/s00213-019-05349-2] PMID: 31463541 PMCID: PMC7458349
  10. Banta-Green CJ, Newman A, Kingston S, Glick S, Tinsley J. Washington State Syringe Exchange Health Survey, 2019 Results. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, 2020
  11. Hatch-Maillette MA, Donovan DM, Laschober TC. Dosage of booster phone calls following an SBIRT intervention in the emergency department for reducing substance use. Journal of Substance Abuse Treatment 2020;116:108043. [doi: 10.1016/j.jsat.2020.108043] PMID: 32741496 PMCID: PMC7399209
  12. Vandersloot D, Stoner S, Hartzler B. Current workforce development priorities for training and technical assistance for integration of behavioral health services in medical settings. [conference abstract]. Addiction Science & Clinical Practice 2020;15(suppl2):A93. [doi: 10.1186/s13722-020-00208-4]
  13. Serafini K, Coyer C, Speights JB, Donovan DM, Guh J, Washington J, Ainsworth C. Racism as experienced by physicians of color in the health care setting. Family Medicine 2020;52(4):282-7. [doi: 10.22454/FamMed.2020.384384] PMID: 32267524
  14. Barbosa-Leiker C, Campbell ANC, Pavlicova M, Scodes J, Burlew AK, Hatch-Maillette MA, Mennenga SE, Mitchell SG, Novo P, Nunes EV, Rotrosen J, Greenfield SF. Substance use and mental health in emerging adult vs. older adult men and women with opioid use disorder. American Journal on Addictions 2020;29(6):536-542. [doi: 10.1111/ajad.13059] PMID: 32438502 PMCID: PMC7657988
  15. Stoner S, Vandersloot D, Hartzler B. Assessing perceived value of behavioral health workforce educational activities: The questions you ask matter. [conference abstract]. Addiction Science & Clinical Practice 2020;15(suppl2):A17. [doi: 10.1186/s13722-020-00208-4]
  16. Carlini BH, Harwick R, Garrett S. Anytime is the right time: A content analysis of marijuana ads in freely distributed print media in western Washington State, USA. Substance Use & Misuse 2020;55:806-817. [doi: 10.1080/10826084.2019.1703749] PMID: 31876238
  17. Schauer GL, Njai R, Grant-Lenzy AM. Modes of marijuana use – smoking, vaping, eating, and dabbing: Results from the 2016 BRFSS in 12 States. Drug and Alcohol Dependence 2020;209:107900. [doi: 10.1016/j.drugalcdep.2020.107900] PMID: 32061947
  18. Peavy KM, Darnton J, Grekin P, Russo M, Banta-Green CJ, Merrill JO, Fotinos C, Wollworth S, Soth S, Tsui JI. Rapid implementation of service delivery changes to mitigate COVID-19 and maintain access to methadone among persons with and at high-risk for HIV in an opioid treatment program. AIDS and Behavior 2020;24:2469-2472. [doi: 10.1007/s10461-020-02887-1] PMID: 32347404 PMCID: PMC7186943
  19. PRSC Cannabis Concentration Workgroup, Carlini B. Cannabis Concentration and Health Risks: A Report for the Washington State Prevention Research Subcommittee (PRSC). Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2020
  20. Humphreys K, Barreto N, Alessi S, Carroll K, Crits-Cristoph P, Donovan DM, Kelly J, Schottenfeld R, Timko C, Wagner T. Impact of 12 step mutual help groups on drug use disorder patients across six clinical trials. Drug and Alcohol Dependence 2020;215;108213. [doi: 10.1016/j.drugalcdep.2020.108213] PMID: 32801112 PMCID: PMC7502458
  21. Hartzler B, Walker DD, Lyon AR, King KM, Matthews L, Ogilvie TL, Bushnell DA, Wicklander K. Applications of standardized patient methodology to enhance workshop training and assess its impact on fidelity in an implementation trial of the Teen Marijuana Check-Up. [conference abstract]. Implementation Science 2020;15(suppl2):A27
  22. Banta-Green CJ, Williams JR, Sears JM, Floyd AS, Tsui JI, Hoeft TJ. Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder. Drug and Alcohol Dependence 2020;207:107799 [doi: 10.1016/J.DRUGALCDEP.2019.107799] PMID: 31865058 PMCID: PMC8085903
  23. McCarty D, Donovan DM. The National Drug Abuse Treatment Clinical Trials Network: From 2000 to 2020 and beyond [editorial]. Journal of Substance Abuse Treatment 2020;112S:1-3. [doi: 10.1016/j.jsat.2020.02.010]
  24. Pedersen ER, Firth CL, Rodriguez A, Shih RA, Seelam R, Kraus L, Dunbar MS, Tucker JS, Kilmer B, D'Amico EJ. Examining associations between licensed and unlicensed outlet density and cannabis outcomes from preopening to postopening of recreational cannabis outlets. American Journal on Addictions 2020;30(2):122-130. [doi: 10.1111/ajad.13132] PMID: 33378105 PMCID: PMC8157480
  25. Torres VN, Williams EC, Ceballos RM, Donovan DM, Ornealas IJ. Participant satisfaction and acceptability of a culturally adapted brief intervention to reduce unhealthy alcohol use among Latino immigrant men. American Journal of Men's Health 2020;14(3):1557988320925652. [doi: 10.1177/1557988320925652] PMID: 32602803 PMCID: PMC7328216
  26. Hartzler B, Carlini BH, Williams JR, Crane HM, Geng EH, Mathews WC, Mayer KH, Moore RD, Mugavero MJ, Napravnik S, Rodriguez B, Donovan DM. Marijuana as a risk factor for discontinuity of care among persons living with HIV/AIDS. [conference abstract]. Cannabis 2020;3(1):93
  27. Schauer GL, Tynan MA, Marynak K. Self-reported exposure to, perceptions about, and attitudes about public marijuana smoking among U.S. adults, 2018. Addiction 2020;115(7):1320-1329. [doi: 10.1111/add.14955] PMID: 31899566 PMCID: PMC8404220
  28. D'Amico EJ, Rodriguez A, Dunbar MS, Firth CL, Tucker JS, Seelam R, Pedersen ER, Davis JP. Sources of cannabis among young adults and associations with cannabis-related outcomes. International Journal of Drug Policy 2020;86:102971. [doi: 10.1016/j.drugpo.2020.102971] PMID: 33038599 PMCID: PMC7770012
  29. Hood JE, Behrends CN, Irwin A, Schackman BR, Chan D, Hartfield K, Hesse J, Banta-Green CJ, Whiteside L, Finegood B, Duchina J. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA. International Journal of Drug Policy 2019;67:9-18. [doi: 10.1016/j.drugpo.2018.12.015] PMID: 30802842
  30. Hartzler B, Dombrowski JC, Donovan DM. Contextual compatibility of three empirically supported behavior therapies for cART adherence among patients with substance use disorders. AIDS Care 2019;31(1):19-24. [doi: 10.1080/09540121.2018.1545985] PMID: 30444130 PMCID: PMC6268161
  31. Hartzler B, Vandersloot D. A learning collaborative focused on skill development in teaching and coaching motivational interviewing. In: Garets, M., Archer S., Kitchens, C., Cochran G., and Gordon, A.J. The 2019 Addiction Health Services Research Conference: Insights, review, and abstracts. [conference abstract]. Substance Abuse 2019;40(4):469-472. [doi: 10.1080/08897077.2019.1688221] PMID: 31847783 PMCID: PMC7849629
  32. Laschober TC, Serovich JM, Brown MJ, Kimberly JA, Lescano CM. Decision readiness to disclose HIV-positive status to family members. Sexually Transmitted Diseases 2019;23(3):636-648. [doi: 10.1097/OLQ.0000000000000966] PMID: 30676486 PMCID: PMC6481178
  33. Banta-Green CJ, King County Drug Trends Workgroup. 2018 Drug Trends Report, King County, WA. Seattle, Alcohol & Drug Abuse Institute, University of Washington, July 2018, 9p.
  34. Becker S, Hartzler B, Garner B. Using the ATTC infrastructure to evaluate implementation strategies: A Type 3 hybrid trial with opioid treatment centers. In: Garets, M., Archer S., Kitchens, C., Cochran G., and Gordon, A.J. The 2019 Addiction Health Services Research Conference: Insights, review, and abstracts. [conference abstract]. Substance Abuse 2019;40(4):469-472. [doi:10.1080/08897077.2019.1688221] PMID: 31847783 PMCID: PMC7849629
  35. Lyons VH, Rivara FP, Yan AN, Currier C, Ballsmith E, Haggerty KP, Whiteside L, Floyd AS, Hajat A, Rowhani-Rahbar A. Firearm-related behaviors following firearm injury: Changes in ownership, carrying and storage. Journal of Behavioral Medicine 2019;42:658-673. [doi: 10.1007/s10865-019-00052-1] PMID: 31367931 PMCID: PMC7508299
  36. Stoner SA. The Intersection Between First Episode Psychosis and Marijuana. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, June 2019, 8p.
  37. Adinoff B, Reiman A. Implementing social justice in the transition from illicit to legal cannabis. American Journal of Drug and Alcohol Abuse 2019;45(6):673-688. [doi: 10.1080/00952990.2019.1674862] PMID: 31634005
  38. Hirchak KA, Herron J, Murphy SM, Donovan DM, Roll JM, Buchwald D, McDonell MG, McPherson S, HONOR Study Team. Assessing the interest and cultural congruence of contingency management as an intervention for alcohol misuse among younger American Indian adults. American Indian and Alaska Native Mental Health Research 2019;26(3):38-57. [doi: 10.5820/aian.2603.2019.38] PMID: 31743414 PMCID: PMC6925541
  39. Stoner SA. Trauma-Informed Care in Behavioral Health: What is the Evidence? Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, April 2019, 10p.
  40. Stoner SA. Increasing Marijuana Use by Older Adults: Causes for Concern. Poster presented at North American Cannabis Summit, January 2019, Los Angeles, CA.
  41. Brown MJ, Serovich JM, Laschober TC, Kimberly JA, Lescano CM. Mediating effects of depressive symptoms on perceived social support and HIV disclosure: assessing moderation by sex. AIDS and Behavior 2019;23(3):636-648. [doi: 10.1007/s10461-018-2369-x] PMID: 30539497 PMCID: PMC6471595
  42. Newman A, Henry C, Banta-Green CJ. “Treat us like individual human beings”: 2018 qualitative interviews with Washington State syringe exchange participants. Alcohol & Drug Abuse Institute, University of Washington, October 2019, 12 p.
  43. Trivers KF, Gentzke AS, Phillips E, Tynan M, Schauer GL. Substances used in electronic vapor products among adults in the United States, 2017. Addictive Behaviors Reports 2019;10:100222. [doi: 10.1016/j.abrep.2019.100222] PMID: 31828201 PMCID: PMC6888746
  44. Hatch-Maillette MA, Harwick R, Baer JS, Masters T, Cloud K, Peavy M, Wiest K, Wright L, Beadnell B, Wells EA. Counselor turnover in substance use disorder treatment research: Observations from one multisite trial. Substance Abuse 2019;40(2):214-220. [doi: 10.1080/08897077.2019.1572051] PMID: 30829142
  45. Stoner SA. Emerging Research on Alcohol Use Disorders: Trends and Treatments. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, June 2019, 16p.
  46. Burgard DA, Williams JR, Westerman D, Rushing R, Carpenter R, LaRock A, Sadetsky J, Clarke J, Fryhle H, Pellman M, Banta-Green CJ. Using wastewater-based analysis to monitor the effects of legalized retail sales on cannabis consumption in Washington State, USA. Addiction 2019;114(9):1582-1590. [doi: 10.1111/add.14641] PMID: 31211480 PMCID: PMC6814135
  47. Hatch-Maillette MA, Harwick R, Baer JS, Masters T, Cloud K, Peavy M, Wiest K, Wright L, Beadnell B, Wells EA. Increasing substance use disorder counselors’ self-efficacy and skills in talking to patients about sex and HIV risk: A randomized training trial. Drug and Alcohol Dependence 2019;199:76-84. [doi: 10.1016/j.drugalcdep.2019.02.023] PMID: 30829142 PMCID: PMC6759413
  48. Banta-Green CJ, Floyd AS, Vick K, Arthur J, Hoeft TJ, Tsui JI. Opioid use disorder treatment decision making and care navigation upon release from prison: A feasibility study. Substance Abuse and Rehabilitation 2019;10:57-67. [doi: 10.2147/SAR.S192045] PMID: 31695555 PMCID: PMC6815213
  49. Walton K, Wang TW, Schauer GL, Hu S, McGruder HF, Jamal A, Babb S. State-specific prevalence of quit attempts among adult cigarette smokers – United States, 2011-2017. MMWR Morbidity and Mortality Weekly Report 2019;68(28):621-626. [doi: 10.15585/mmwr.mm6828a1] PMID: 31318853 PMCID: PMC6657770
  50. Newman A, Banta-Green CJ. Peer support groups and medications for opioid use disorder: Perspectives from individuals and care providers. Alcohol & Drug Abuse Institute, University of Washington, June 2019, 12 p.
  51. Carlini B, Sirotzki A. Health Risks Associated with e-Cigarettes, Vaping, and JUUL. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, June 2019, 7p.
  52. Finlay AK, Owens MD, Taylor E, Nash A, Capdarest-Arest N, Rosenthal J, Blue-Howells J, Clark S, Timko C. A scoping review of military veterans involved in the criminal justice system and their health and healthcare. Health & Justice 2019;7(1):6. [doi: 10.1186/s40352-019-0086-9] PMID: 30963311 PMCID: PMC6718001
  53. Stoner SA. Potency of Cannabis. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, June 2019, 5p.
  54. Scheuermann TS, Preacher KJ, Carlini BH, Bush T, Magnusson B, Nazir N, Richter KP. Predictors of engagement in post-discharge quitline counseling among hospitalized smokers. Journal of Behavioral Medicine 2019;42(1):139-149. [doi: 10.1007/s10865-018-9951-6] PMID: 30027388 PMCID: PMC7073259
  55. Brown MJ, Serovich JM, Laschober TC, Kimberly JA, Lescano CM. Ways of coping and HIV disclosure among people living with HIV: mediation of decision self-efficacy and moderation by sex. AIDS Care 2019;31(8):1001-1010. [doi: 10.1080/09540121.2019.1605045] PMID: 30974958 PMCID: PMC6560623
  56. McCrady BS, Tonigan JS, Ladd BO, Hallgren KA, Pearson MR, Owens MD, Epstein EE. Alcohol Behavioral Couple Therapy: in-session behavior, active ingredients and mechanisms of behavior change. Journal of Substance Abuse Treatment 2019;99:139-148. [doi: 10.1016/j.jsat.2019.01.018] PMID: 30797386 PMCID: PMC6478165
  57. Stoner SA. People at Risk for Problems with Cannabis. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, June 2019, 5p.
  58. Banta-Green CJ, Coffin PO, Merrill JO, Sears JM, Dunn C, Floyd AS, Whiteside LK, Yanez ND, Donovan DM. Impacts of an opioid overdose prevention intervention delivered subsequent to acute care. Injury Prevention 2019;25(3):191-198. [doi: 10.1136/injuryprev-2017-042676] PMID: 29436397 PMCID: PMC6800078
  59. Nance RM, Trejo MEP, Whitney BM, Delaney JAC, Altice F, Beckwith CG, Chander G, Chandler R, Christopoulous K, Cunningham C, Cunningham WE, Del Rio C, Donovan DM, Eron JJ, Fredericksen RJ, Kahana S, Kitahata MM, Kronmal R, Kuo I, Kurth A, Mathews WC, Mayer KH, Moore RD, Mugavero MJ, Ouellet LJ, Quan VM, Saag MS, Simoni JM, Springer S, Strand L, Taxman F, Young JD, Crane HM. Impact of abstinence and of reducing illicit drug use without abstinence on HIV viral load. Clinical Infectious Disease 2019 Apr 17. pii: ciz299. [doi: 10.1093/cid/ciz299] PMID: 30994900 PMCID: PMC7319266
  60. Firth CL, Maher JE, Dilley J, Darnell A, Lovrich NP. Did marijuana legalization in Washington state reduce racial disparities in adult marijuana arrests? Substance Use & Misuse 2019;54(9):1582-1587. [doi: 10.1080/10826084.2019.1593007] PMID: 31096823 PMCID: PMC6948106
  61. Stoner SA. Marijuana and Prescribed Medications. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, June 2019, 8p.
  62. Ornelas IJ, Doyle SR, Serrano S, Torres V, Duran B, Donovan DM. Vida PURA: Results from a pilot randomized trial of a culturally adapted screening and brief intervention to reduce unhealthy alcohol use among Latino day laborers. Translational Behavioral Medicine 2019;9(6):1233-1243. [doi: 10.1093/tbm/ibz071] PMID: 31206579 PMCID: PMC6875653
  63. O’Neal TJ, Nooney MN, Thien K, Ferguson SM. Chemogenetic modulation of accumbens direct or indirect pathways bidirectionally alters reinstatement of heroin-seeking in high- but not low-risk rats. Neuropsychopharmacology 2020;45:1251-1262. [doi:10.1038/s41386-019-0571-9] PMID: 31747681 PMCID: PMC7297977
  64. Merrill JE, Miller MB, DiBello AM, Singh S, Carey KB. How do college students subjectively evaluate “blackouts”? Addictive Behaviors 2019;89(65-69). [doi: 10.1016/j.addbeh.2018.09.022] PMID: 30261483 PMCID: PMC6240386
  65. McMahan VM, Martin A, Garske L, Violette LR, Andrasik MP, Baeten JM, Banta-Green CJ, Stekler JD. Development of a targeted educational intervention to increase pre-exposure prophylaxis uptake among cisgender men and transgender individuals who have sex with men and use methamphetamine in Seattle (WA, USA). Sexual Health 2019;16(2):139-147. [doi: 10.1071/SH18060] PMID: 30739638
  66. Campus P, Covelo IR, Kim Y, Parsegian A, Kuhn BN, Lopez SA, Neumaier JF, Ferguson SM, Solberg Woods LC, Sarter M, Flagel SB. The paraventricular thalamus is a critical mediator of top-down control of cue-motivated behavior in rats. Elife 2019 Sep 10;8. pii: e49041. [doi: 10.7554/eLife.49041] PMID: 31502538 PMCID: PMC6739869
  67. Wendt DC, Hartmann WE, Allen J, Burack JA, Charles B, D’Amico EJ, Dell CA, Dickerson DL, Donovan DM, Gone JP, O’Connor RM, Radin SM, Rasmus SM, Venner KL, Walls ML. Substance use research with indigenous communities: Exploring and extending foundational principles of community psychology. American Journal of Community Psychology 2019;64(1-2):146-158. [doi: 10.1002/ajcp.12363] PMID: 31365138 PMCID: PMC6777961
  68. Anastasio NC, Stutz SJ, Price AE, Davis-Reyes BD, Sholler DJ, Ferguson SM, Neumaier JF, Moeller FG, Hommel JD, Cunningham KA. Convergent neural connectivity in motor impulsivity and high-fat food binge-like eating in male Sprague-Dawley rats. Neuropsychopharmacology 2019;44(10):1752-1761. [doi: 10.1038/s41386-019-0394-8] PMID: 31003231 PMCID: PMC6785029
  69. Firth CL, Carlini BH. Cannabis Legalization and Racial Disparities in Washington State: Criminal Justice, Use by Youth, and Treatment Admissions. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, March 2019, 9p.
  70. Hartzler B, Vandersloot D. Workforce development priorities and learning preferences for evidence-based practices and care processes [Abstract of poster presented at 42nd annual meeting of AMERSA]. Substance Abuse 2019:40(1):Supplemental material, p. 13. [doi: 10.1080/08897077.2019.1613824] PMID: 31180808
  71. Marynak KL, Ali FRM, Schauer GL, Tynan MA, King BA. Use and reasons for use of electronic vapour products shaped like USB flash drives among a national sample of adults. Tobacco Control 2019;28(6):685-688. [doi: 10.1136/tobaccocontrol-2019-054932] PMID: 31023856 PMCID: PMC11017232
  72. Hartzler B, Vandersloot D, Brunner M, Donovan DM, Carlini BH. Web-assisted training in contingency management: A customized yet scalable product For multi-tiered personnel in addiction treatment settings. [Abstract of poster presented at 42nd annual meeting of AMERSA]. Substance Abuse 2019:40(1):Supplemental material, p. 14-15. [doi: 10.1080/08897077.2019.1613824] PMID: 31180808
  73. Frost MC, Williams EC, Kingston S, Banta-Green CJ. Interest in getting help to reduce or stop substance use among syringe exchange clients who use opioids. Journal of Addiction Medicine 2018;12:(6):428–434. [doi: 10.1097/ADM.0000000000000426] PMID: 29889118
  74. Berg CJ, Henriksen L, Cavazos-Rehg P, Schauer GL. Point-of-sale marketing and context of marijuana retailers: Assessing reliability and generalizability of the marijuana retail surveillance tool. Preventive Medicine Reports 2018;11:37-41. [doi: 10.1016/j.pmedr.2018.05.010] PMID: 2998413 PMCID: PMC6030680
  75. Berg CJ, Payne J, Henriksen L, Cavazos-Reh P, Getachew B, Schauer GL, Haardorfer R. Reasons for marijuana and tobacco co-use among young adults: A mixed methods scale development study. Substance Use & Misuse 2018;53(3):357-369. [doi: 10.1080/10826084.2017.1327978] PMID: 28792283 PMCID: PMC5890801
  76. Grant TM, Graham JC, Carlini BH, Ernst CC, Brown NN. Use of marijuana and other substances among pregnant and parenting women with substance use disorders: changes in Washington State after marijuana legalization. Journal of Studies on Alcohol and Drugs 2018;79(1):88-95. [doi: 10.15288/jsad.2018.79.88] PMID: 29227236
  77. Hood JE, Buskin SE, Golden MR, Glick SN, Banta-Green CJ, Dombrowski JC. The changing burden of HIV attributable to methamphetamine among men who have sex with men in King County, Washington. AIDS Patient Care and STDS 2018;32(6):223-233. [doi: 10.1089/apc.2017.0306] PMID: 29851502
  78. Yager LM, Garcia AF, Donckels EA, Ferguson SM. Chemogenetic inhibition of direct pathway striatal neurons normalizes pathological, cue-induced reinstatement of drug-seeking in rats. Addiction Biology 2019;24(2):251-264. [doi: 10.1111/adb.12594] PMID: 29314464 PMCID: PMC6033698
  79. Carlini BH. Role of Medicinal Cannabis as Substitute for Opioid Use to Control Chronic Pain: Separating Popular Myth from Science and Medicine. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, February 2018, 6p.
  80. Stoner SA. Marijuana and Sexual Risk Behavior in Youth and Emerging Adults: What Do We Know? Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, June 2018, 9p.
  81. Stoner SA. Effective Treatments for Methamphetamine Use Disorder: A Review. Seattle: Alcohol & Drug Abuse Institute, University of Washington, April 2018, 15 p.
  82. Banta-Green CJ, Williams JR, King County Community Epidemiology Workgroup. Drug Use Trends in King County, Washington, 2017. Seattle: Alcohol & Drug Abuse Institute, University of Washington, May 2018, 14 p.
  83. Carlini BH. Medical Cannabis and Opioid-related Deaths: What is the Evidence? Alcohol & Drug Abuse Institute, University of Washington, December 2018, 6p.
  84. Campbell ANC, Barbosa-Leiker C, Hatch-Maillette M, Mennenga SE, Pavlicova M, Scodes J, Saraiya T, Mitchell SG, Rotrosen J, Novo P, Nunes EV, Greenfield SF. Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial; Brief report. American Journal on Addictions 2018;27(6):465-470. [doi: 10.1111/ajad.12784] PMID: 30106494 PMCID: PMC6124662
  85. Banta-Green CJ, Cooley L. The Role of Medications in the Treatment of Adolescents and Young Adults with Opioid Use Disorder. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, November 2018, 28p.
  86. Bird ER, Seehuus M, Heiman JR, Davis KC, Norris J, George WH. Sexual vs. nonsexual currently most upsetting trauma: A fresh look at attenuation of sexual response, alcohol intoxication, and post-traumatic stress. Journal of Sex Research 2018;55(7):915-926. [doi: 10.1080/00224499.2017.1380159] PMID: 29023137 PMCID: PMC6195219
  87. Hartzler B, Dombrowski JC, Williams JR, Crane HM, Eron JJ, Geng EH, Mathews C, Mayer KH, Moore RD, Mugavero MJ, Napravnik S, Rodriguez B, Donovan DM. Influence of substance use disorders on 2-Year HIV care retention in the United States. AIDS and Behavior 2018;22(3):742-751. [doi: 10.1007/s10461-017-1826-2] PMID: 28612213 PMCID: PMC5729068
  88. Brown MJ, Serovich JM, Laschober TC, Kimberly JA. Age and racial disparities in substance use and self-reported viral suppression among men who have sex with men with HIV. International Journal of STD & AIDS 2018;29(12):1174-1182. [doi: 10.1177/0956462418779663] PMID: 29945540 PMCID: PMC6698904
  89. Serrano SE, Serafini K, Eller N, Torres VN, Donovan DM, Ornelas IJ. Vida PURA: An assessment of the fidelity of promotor-delivered screening and brief intervention to reduce unhealthy alcohol use among Latino day laborers. Journal of Ethnicity in Substance Abuse 2018;17(4):519-531. [doi: 10.1080/15332640.2017.1300557] PMID: 28375699 PMCID: PMC7141813
  90. Banta-Green CJ, Newman A, Kingston S. Washington State Syringe Exchange Health Survey: 2017 Results. Seattle: Alcohol & Drug Abuse Institute, University of Washington, January 2018.
  91. Stoner SA, Williams JR, Newman A, Sutherland NL, Banta-Green CJ. Methamphetamine in Washington: Report to the Division of Behavioral Health and Recovery. Seattle: Alcohol & Drug Abuse Institute, University of Washington, June 2018, 35p. (includes appendices)
  92. Serovich JM, Reed SJ, O'Connell AA, Laschober TC. Relationship between serostatus disclosure and categories of HIV transmission risk in men who have sex with men living with HIV. International Journal of STD & AIDS 2018;29(8):744-750. [doi: 10.1177/0956462417752267] PMID: 29431024
  93. Stoner SA. Evidence-based Practices in Washington State: Report to DBHR. Seattle: Alcohol & Drug Abuse Institute, University of Washington, September 2018, 63 p. (includes appendices)
  94. Garrett SB, Doyle SR, Peavy MK, Wells EA, Owens MD, Shores-Wilson K, DiCenzo J, Donovan DM. Age differences in outcomes among patients in the “Stimulant Abuser Groups to Engage in 12-Step” (STAGE-12) intervention. Journal of Substance Abuse Treatment 2018;84:21-29. [doi: 10.1016/j.jsat.2017.10.012] PMID: 29195590 PMCID: PMC5726800
  95. Stoner SA. Cognitive and Behavioral Risk Correlates of Marijuana Use by Older Adults. Poster presented at Research Society on Marijuana (RSMj), June 2018, Fort Collins, CO.
  96. Serafini K, Stewart DG, Wendt DC, Donovan DM. Perceived parental support and adolescent motivation for substance use change: a preliminary investigation. Addiction Research & Theory 2018;26(3):187-192. [doi: 10.1080/16066359.2017.1342819]
  97. Serovich JM, Laschober TC, Brown MJ, Kimberly JA. Assessment of HIV disclosure and sexual behavior among Black men who have sex with men following a randomized controlled intervention. International Journal of STD & AIDS 2018;29(7):673-679. [doi: 10.1177/0956462417751812] PMID: 29361887 PMCID: PMC6701171
  98. Schauer GL, Peters EN. Correlates and trends in youth co-use of marijuana and tobacco in the United States, 2005-2014. Drug and Alcohol Dependence 2018;185:238-244. [doi: 10.1016/j.drugalcdep.2017.12.007] PMID: 29471228
  99. Stoner SA. Marijuana Source Assessment Matrix: What Do We Want to Know About Marijuana Access? Seattle: Alcohol & Drug Abuse Institute, University of Washington, December 2018, 16p.
  100. Glick SN, Burt R, Kummer K, Tinsley J, Banta-Green CJ, Golden MR. Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. Drug and Alcohol Dependence 2018;182:86–92. [doi: 10.1016/j.drugalcdep.2017.10.011] PMID: 29175463 PMCID: PMC6457905